World's Best Scientists 2026 revealed!
Robert S. Wallis

Robert S. Wallis

D-Index & Metrics

Immunology

D-Index
70
Citations
16315
World Ranking
2430
National Ranking
10

Overview

Robert S. Wallis is affiliated with the Aurum Institute in South Africa, specializing in research predominantly within the field of Medicine. Their scholarly work focuses extensively on Infectious Diseases, Epidemiology, and Pulmonary and Respiratory Medicine, with additional contributions to Surgery and Molecular Biology.

The scientist's research covers several key topics, including:

  • Tuberculosis Research and Epidemiology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Infectious Diseases and Tuberculosis
  • Mycobacterium research and diagnosis
  • Pneumonia and Respiratory Infections
  • SARS-CoV-2 and COVID-19 Research

Robert S. Wallis has collaborated frequently with colleagues such as Gavin Churchyard, Pholo Maenetje, Salome Charalambous, Norbert Heinrich, and Stellah Mpagama.

They have contributed to several notable publication venues, including:

  • PLoS ONE
  • The International Journal of Tuberculosis and Lung Disease
  • Gates Open Research
  • SSRN Electronic Journal
  • The Lancet Respiratory Medicine

Among recent papers authored or co-authored by Robert S. Wallis are:

  • Host-directed immunotherapy of viral and bacterial infections: past, present and future, 2022, Nature reviews. Immunology
  • Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial, 2021, The Lancet Respiratory Medicine
  • Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae, 2021, The Lancet Global Health
  • Clinical standards for the assessment, management and rehabilitation of post-TB lung disease, 2021, The International Journal of Tuberculosis and Lung Disease
  • Post-tuberculosis lung health: perspectives from the First International Symposium, 2020, The International Journal of Tuberculosis and Lung Disease

Best Publications

  • Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists

    R. S. Wallis;M. S. Broder;J. Y. Wong;M. E. Hanson

  • Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

    Robert S Wallis;Madhukar Pai;Madhukar Pai;Dick Menzies;Dick Menzies;T Mark Doherty

  • The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

    I. Solovic;M. Sester;J. J. Gomez-Reino;H. L. Rieder

  • High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

    Martin J Boeree;Norbert Heinrich;Rob Aarnoutse;Andreas H Diacon

  • Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

    Alimuddin Zumla;Alimuddin Zumla;Martin Rao;Martin Rao;Robert S Wallis;Stefan H E Kaufmann

  • Depressed T-Cell Interferon-γ Responses in Pulmonary Tuberculosis: Analysis of Underlying Mechanisms and Modulation with Therapy

    Christina S. Hirsch;Zahra Toossi;Catherine Othieno;John L Johnson

  • Tumour necrosis factor antagonists: structure, function, and tuberculosis risks.

    Robert S Wallis;Robert S Wallis

  • Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection

    Jason D. Simmons;Catherine Marie Stein;Chetan Seshadri;Monica Campo

  • Advancing host-directed therapy for tuberculosis

    Robert S. Wallis;Richard Hafner

  • Biomarkers for tuberculosis disease activity, cure, and relapse

    Robert S. Wallis;T. Mark Doherty;Phillip Onyebujoh;Mahnaz Vahedi

  • Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers

    Robert S Wallis;Markus Maeurer;Peter Mwaba;Jeremiah Chakaya

  • Tuberculosis biomarkers discovery: developments, needs, and challenges

    Robert S Wallis;Robert S Wallis;Robert S Wallis;Peter Kim;Stewart Cole;Debra Hanna

  • Host-directed immunotherapy of viral and bacterial infections: past, present and future

    Unknown

  • A study of the safety immunology virology and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis.

    Robert S. Wallis;Peter Kyambadde;John L. Johnson;Libby Horter

  • Granulomatous Infections Due to Tumor Necrosis Factor Blockade: Correction

    Robert S. Wallis;Michael Broder;John Wong;David Beenhouwer

  • Tumor Necrosis Factor Antagonists: Different Kinetics and/or Mechanisms of Action May Explain Differences in the Risk for Developing Granulomatous Infection

    Daniel E. Furst;Robert Wallis;Michael Broder;David O. Beenhouwer

  • Tumor-Necrosis-Factor Blockers: Differential Effects on Mycobacterial Immunity

    Oluwabunmi Y. Saliu;Carolina Sofer;Dana S. Stein;Stephan K. Schwander

  • Reactivation of latent granulomatous infections by infliximab

    Robert S. Wallis;Michael Broder;John Wong;Albert Lee

  • Human immune response to Mycobacterium tuberculosis antigens.

    D V Havlir;R S Wallis;W H Boom;T M Daniel

  • Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot

    R S Wallis;M Amir-Tahmasseb;J J Ellner

  • Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes

    Timothy K. Blackmore;Laurens Manning;William J. Taylor;Robert S. Wallis

Frequent Co-Authors

Jerrold J. Ellner
Jerrold J. Ellner Rutgers, The State University of New Jersey
John L. Johnson
John L. Johnson Case Western Reserve University
Gavin J. Churchyard
Gavin J. Churchyard Aurum Institute
Alimuddin Zumla
Alimuddin Zumla University College London
Markus Maeurer
Markus Maeurer Champalimaud Foundation
Michael Hoelscher
Michael Hoelscher Ludwig-Maximilians-Universität München
T. Mark Doherty
T. Mark Doherty Danish Institute for Study Abroad
Beate Kampmann
Beate Kampmann Charité - University Medicine Berlin
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
Hardy Kornfeld
Hardy Kornfeld University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees online can broaden career opportunities. Nursing programs often serve as practical complements, especially roles focused on patient care and clinical treatment of immune-related conditions.

Many aspiring nurses begin by enrolling in accredited LPN programs easy to get into, which provide foundational training and a fast track into the healthcare field. These programs are ideal for those looking to build experience while continuing their education.

Advancement often comes through more specialized studies like nurse practitioner degrees. The easiest NP programs to get into allow students to gain advanced clinical skills and expand their scope of practice, including immunology-focused patient care.

For those interested in mental health and immunological implications on psychiatric conditions, pursuing a Psychiatric Mental Health Nurse Practitioner (PMHNP) degree is an excellent option. The top online PMHNP programs offer strong clinical placement rates to ensure hands-on experience.

Additionally, cost-conscious students can find quality education through cheapest psychiatric nurse practitioner programs that deliver value without compromising on accreditation or clinical opportunities.

By combining immunology studies with accessible nursing pathways, students can tailor careers that blend research, clinical expertise, and patient-centered care in innovative healthcare environments.

Best Scientists Citing Robert S. Wallis

Trending Scientists

Recently Published Articles